Jazz Pharmaceuticals (JAZZ) PT Raised to $225 at Barclays
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $245.85 -1.25%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Barclays analyst Balaji Prasad raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $225.00 (from $205.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Resideo Technologies (REZI) PT Lowered to $27 at Oppenheimer
- Adyen NV (ADYEN:NA) (ADYYF) PT Raised to EUR1,200 at Susquehanna
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
